product_view

본문바로가기

Novavax COVID-19 Vaccine 2023-2024 formula (Emergency Use Authorization)

Category: ETC

Indication(s)·Usage

To prevent COVID-19 caused by SARS-CoV-2 in individuals 12 years of age and older

Effective components: SARS-CoV-2 spike protein(recombinant)(Host cell: Sf9, Vector: BV2601)

Active ingredient(s) and Contents

Effective components
- SARS-CoV-2 spike protein(recombinant)(Host cell: Sf9, Vector: BV2601)
Other
- Sodium dihydrogen phosphate monohydrate, Sodium chloride, Water for injections, Matrix-M, Disodium hydrogen phosphate heptahydrate, Polysorbate80, Sodium hydroxide, Hydrochloric acid

Dosage and administration

1. Dosage
This drug (Novavax COVID-19 vaccine 2023-2024 formula) is administered intramuscularly as a single dose(0.5 mL) regardless of previous COVID-19 vaccination.
For individuals who have previously been vaccinated with a COVID-19 vaccine, this drug should be administered at least 3 months after the most recent dose of a COVID-19 vaccine.

2. Method of Administration
This drug is for intramuscular injection only, preferably into the deltoid muscle of the upper arm.
Do not inject the vaccine intravascularly, subcutaneously, or intradermally.

1 dose should contain 0.5mL regardless of the type of syringe and needle.
Do not pool excess vaccine from vials.
1. The vaccine should not be mixed in the same syringe with any other vaccines or medicinal products.
2. For precautions regarding administration, see section ’10. Precautions for Handling’.

Storage and handling

Keep in an air-tight container, out of direct light and under refrigeration conditions (2°C to 8°C), Do not freeze